Volume 10, Number 5—May 2004
Research
Clinical Manifestations, Laboratory Findings, and Treatment Outcomes of SARS Patients
Jann-Tay Wang*, Wang-Huei Sheng*, Chi-Tai Fang*, Yee-Chun Chen*, Jiun-Ling Wang*, Chong-Jen Yu*, Shan-Chwen Chang*
, and Pan-Chyr Yang*
, and Pan-Chyr Yang*Table 1
Demographic data and initial clinical signs and symptoms of 76 patients with probable SARSa
| Data | No. of cases (%) |
|---|---|
| Sex |
|
| Male |
34 (44.7) |
| Female |
42 (55.3) |
| Age (y) (range, median) |
24–87 (46.5) |
| Underlying disease (no.) |
|
| Nonfatal |
62 (81.6) |
| No underlying disease |
52 (68.4) |
| Mild underlying disease |
10 (13.2) |
| Ultimately fatal |
3 (3.9) |
| Rapidly fatal |
11 (14.5) |
| Initial symptoms |
|
| Fever |
76 (100) |
| Cough |
47 (61.8) |
| Myalgia |
37 (48.7) |
| Dyspnea |
31 (40.8) |
| Diarrhea |
24 (31.6) |
| Rigor |
23 (30.3) |
| Headache |
14 (18.4) |
| Nausea |
9 (11.8) |
| Sore throat |
7 (9.2) |
| Vomiting |
3 (3.9) |
| Rhinorrhea | 2 (2.6) |
aSARS, severe acute respiratory syndrome.
